# Lisata Therapeutics, Inc.: Form 8-K, filed Oct 14, 2026

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2026-10-14
- Accepted by EDGAR: Oct 14, 2026, 16:25 ET
- Period: 2026-10-13
- Accession: 0001140361-26-039602
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000114036126039602/ef20083796_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000114036126039602/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000114036126039602/ef20083796_8k.htm

Filed Oct 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-039602. Last ingested by Listed: Nov 10, 2026, 04:21 ET. No prices; not investment advice.